drugset / Trial / NCT02550756

Study to Evaluate the Safety and Tolerability of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)

NCT02550756

Phase 1 Completed 11 enrolled Centrexion Therapeutics
RandomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to confirm that the local anesthetic applied to subjects with Morton's Neuroma satisfactorily mitigates procedure pain and ensures that post-procedure discomfort or pain will not result in bias or breaking of the blind in the planned Phase 2b study.

Timeline

Start
2014-02
Primary completion
2014-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Capsaicin Small molecule 0.2 mg
Subject Capsaicin Small molecule 0.6 mg

Indications